Hypertension Home > Generic Teveten HCT

There are currently no generic Teveten HCT (eprosartan/HCTZ) products available. The first patent for this medication is set to expire in August 2014, which is the earliest predictable date that a generic version could be manufactured. However, lawsuits or other patents for new uses of Teveten HCT may delay the manufacturing of a generic version.

Can I Buy Generic Teveten HCT?

Teveten® HCT (eprosartan/HCTZ) is a prescription medication used to treat high blood pressure, known medically as hypertension. It is a combination medication, containing two different high blood pressure medications. Eprosartan (Teveten) is an angiotensin II receptor blocker; hydrochlorothiazide (Microzide®, Oretic®), or HCTZ for short, is a diuretic or "water pill."
Teveten HCT is made by Solvay Pharmaceuticals for Abbott Laboratories. It is currently under the protection of a patent that prevents any generic Teveten HCT from being manufactured in the United States.

When Will a Generic Version Be Available?

The first patent for Teveten HCT is set to expire in August 2014. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Teveten HCT uses. Once the patent expires, there may be several companies that manufacture a generic Teveten HCT drug.

Is It Cheaper to Take Teveten and HCTZ Separately?

In general, it is unlikely that taking the two components (Teveten and hydrochlorothiazide) separately would result in significant savings. Teveten is not available in generic form and is usually priced similarly, compared to Teveten HCT; plus, you would have the additional cost of a separate hydrochlorothiazide prescription.
If you are having trouble paying for Teveten HCT, talk with your healthcare provider or pharmacist about ways to afford your medications. You may qualify for special assistance; if not, your healthcare provider may recommend that you switch to a more affordable medication.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.